drugset / Trial / NCT01081561

Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs

NCT01081561

Phase 2/3 Unknown 600 enrolled Yaron S. Rabinowitz M.D.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will determine the efficacy of collagen cross linking for progressive keratoconus and ectasia after lasik. It will try and determine which is a more effective treatment: collagen cross linking alone or collagen cross linking combined with Intacs, a treatment which has already been proven to be effective in decreasing corneal curvature in patients with keratoconus.

Timeline

Start
2009-01-21
Primary completion
2020-12-30
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified Topical